Generics

We manufacture our products by following our customers’ and health authorities’ most stringent requirements. DMF documentation for all our products is prepared in accordance with the latest requirements 
of EDQM (CEP), ICH (ASMF in eCTD format), and FDA (US DMF). Material and product testing is performed in line with the European and United States Pharmacopeias.

Status

Therapeutic Category

Polymorphic form

CAS No.

    S
  • Sitagliptin hydrochloride

    StatusCommercial

    Therapeutic CategoryAlimentary tract & metabolism

    Polymorphic formPolymorphic form III

    CAS No.862156-92-1

    View more
  • Sodium salicylate

    StatusCommercial

    Therapeutic CategoryAlimentary tract & metabolism

    Polymorphic formMonoclinic form (space group P21/m)

    CAS No.54-21-7

    View more